Sheaff Brock Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-22,000
| Closed | -$198K | – | 497 |
|
|
2020
Q3 | $198K | Sell |
22,000
-500
| -2% | -$4.5K | 0.02% | 390 |
|
|
2020
Q2 | $277K | Sell |
22,500
-360
| -2% | -$4.43K | 0.03% | 314 |
|
|
2020
Q1 | $205K | Sell |
22,860
-6,000
| -21% | -$53.8K | 0.03% | 327 |
|
|
2019
Q4 | $283K | Buy |
28,860
+17,200
| +148% | +$169K | 0.03% | 340 |
|
|
2019
Q3 | $80K | Sell |
11,660
-500
| -4% | -$3.43K | 0.01% | 440 |
|
|
2019
Q2 | $112K | Buy |
12,160
+589
| +5% | +$5.43K | 0.01% | 448 |
|
|
2019
Q1 | $181K | Buy |
+11,571
| New | +$181K | 0.02% | 441 |
|
|
2018
Q3 | – | Sell |
-8,344
| Closed | -$203K | – | 533 |
|
|
2018
Q2 | $203K | Sell |
8,344
-2,000
| -19% | -$48.7K | 0.02% | 443 |
|
|
2018
Q1 | $177K | Buy |
+10,344
| New | +$177K | 0.02% | 457 |
|
|
2017
Q3 | – | Sell |
-8,389
| Closed | -$279K | – | 613 |
|
|
2017
Q2 | $279K | Buy |
8,389
+294
| +4% | +$9.78K | 0.04% | 398 |
|
|
2017
Q1 | $260K | Buy |
8,095
+177
| +2% | +$5.69K | 0.03% | 434 |
|
|
2016
Q4 | $287K | Buy |
+7,918
| New | +$287K | 0.04% | 417 |
|
|
2016
Q3 | – | Sell |
-4,708
| Closed | -$237K | – | 591 |
|
|
2016
Q2 | $237K | Buy |
4,708
+300
| +7% | +$15.1K | 0.03% | 437 |
|
|
2016
Q1 | $236K | Buy |
4,408
+1
| +0% | +$54 | 0.03% | 447 |
|
|
2015
Q4 | $289K | Buy |
+4,407
| New | +$289K | 0.03% | 423 |
|